Ítem
Acceso Abierto

Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
dc.creator | Torres-Morales, Elizabeth | spa |
dc.creator | Taborda, Laura | spa |
dc.creator | Cardona, Nestor | spa |
dc.creator | de-la-Torre, Alejandra | spa |
dc.creator | Sepulveda-Arias, Juan Carlos | spa |
dc.creator | Patarroyo, Manuel A. | |
dc.creator | Gomez-Marin, Jorge Enrique | spa |
dc.date.accessioned | 2020-05-25T23:56:57Z | |
dc.date.available | 2020-05-25T23:56:57Z | |
dc.date.created | 2014 | spa |
dc.description.abstract | We determined the specific lymphocyte proliferative response and cytokine profile production regarding Toxoplasma P30 (2017 from virulent and non-virulent strain) and ROP18 protein-derived peptides (from clonal lineages I, II and III) in 19 patients having ocular toxoplasmosis, five suffering chronic asymptomatic infection, nine with congenital toxoplasmosis and eight Toxoplasma negative people. A Beckman Coulter FC500 flow cytometer was used for determining antigen-specific T cells (CD3+ CD4+ or CD3+ CD8+ cells) in peripheral blood culture. IFN ? and IL10 levels were determined in culture supernatants. Specific CD4+ and CD8+ T cell response to total antigen and P30- and ROP18-derived peptides was observed in infected people. Ocular toxoplasmosis patients had a preferential Th2 response after antigenic stimulation. Non-virulent peptide 2017 was able to shift response toward Th1 in congenitally infected children and virulent peptide 2017 induced a Th2 response in chronically infected, asymptomatic people. An immune response in human toxoplasmosis after ex vivo antigenic stimulation was Th1- or Th2-skewed, depending on a patient’s clinical condition. Colombian ocular toxoplasmosis patients’ immune response was Th2-skewed, regardless of the nature of antigen stimulus. © 2014, Springer-Verlag Berlin Heidelberg. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1007/s00430-014-0339-0 | |
dc.identifier.issn | 14321831 | |
dc.identifier.issn | 03008584 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/22571 | |
dc.language.iso | eng | spa |
dc.publisher | Springer Verlag | spa |
dc.relation.citationEndPage | 322 | |
dc.relation.citationIssue | No. 5 | |
dc.relation.citationStartPage | 315 | |
dc.relation.citationTitle | Medical Microbiology and Immunology | |
dc.relation.citationVolume | Vol. 203 | |
dc.relation.ispartof | Medical Microbiology and Immunology, ISSN:14321831, 03008584, Vol.203, No.5 (2014); pp. 315-322 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84919477257&doi=10.1007%2fs00430-014-0339-0&partnerID=40&md5=4b6c72c20def77684d4ff6b2fb732f31 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | CD3 antigen | spa |
dc.subject.keyword | CD4 antigen | spa |
dc.subject.keyword | Protozoan | eng |
dc.subject.keyword | Toxoplasma | eng |
dc.subject.keyword | CD | eng |
dc.subject.keyword | Mononuclear | eng |
dc.subject.keyword | Toxoplasma gondii | eng |
dc.subject.keyword | CD8 antigen | spa |
dc.subject.keyword | Gamma interferon | spa |
dc.subject.keyword | Interleukin 10 | spa |
dc.subject.keyword | Protein p30 | spa |
dc.subject.keyword | ROP18 protein | spa |
dc.subject.keyword | Tumor necrosis factor alpha | spa |
dc.subject.keyword | Unclassified drug | spa |
dc.subject.keyword | Virulence factor | spa |
dc.subject.keyword | Cytokine | spa |
dc.subject.keyword | Leukocyte antigen | spa |
dc.subject.keyword | Parasite antigen | spa |
dc.subject.keyword | Protein serine threonine kinase | spa |
dc.subject.keyword | Protozoal protein | spa |
dc.subject.keyword | ROP18 protein | eng |
dc.subject.keyword | SAG1 antigen | eng |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Antigen specificity | spa |
dc.subject.keyword | Article | spa |
dc.subject.keyword | Asymptomatic disease | spa |
dc.subject.keyword | Carboxy terminal sequence | spa |
dc.subject.keyword | CD4+ T lymphocyte | spa |
dc.subject.keyword | CD8+ T lymphocyte | spa |
dc.subject.keyword | Child | spa |
dc.subject.keyword | Clinical article | spa |
dc.subject.keyword | Controlled study | spa |
dc.subject.keyword | Cytokine production | spa |
dc.subject.keyword | Ex vivo study | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Human cell | spa |
dc.subject.keyword | Immune response | spa |
dc.subject.keyword | Immunostimulation | spa |
dc.subject.keyword | Male | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Parasite virulence | spa |
dc.subject.keyword | Th1 cell | spa |
dc.subject.keyword | Th2 cell | spa |
dc.subject.keyword | Toxoplasmosis | spa |
dc.subject.keyword | Adolescent | spa |
dc.subject.keyword | Cell proliferation | spa |
dc.subject.keyword | Chemistry | spa |
dc.subject.keyword | Flow cytometry | spa |
dc.subject.keyword | Immunology | spa |
dc.subject.keyword | Middle aged | spa |
dc.subject.keyword | Mononuclear cell | spa |
dc.subject.keyword | Secretion (process) | spa |
dc.subject.keyword | T lymphocyte subpopulation | spa |
dc.subject.keyword | Th1 cell | spa |
dc.subject.keyword | Th2 cell | spa |
dc.subject.keyword | Toxoplasmosis | spa |
dc.subject.keyword | Young adult | spa |
dc.subject.keyword | Adolescent | spa |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Antigens | eng |
dc.subject.keyword | Antigens | eng |
dc.subject.keyword | CD4-Positive T-Lymphocytes | spa |
dc.subject.keyword | CD8-Positive T-Lymphocytes | spa |
dc.subject.keyword | Cell Proliferation | spa |
dc.subject.keyword | Child | spa |
dc.subject.keyword | Cytokines | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Flow Cytometry | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Leukocytes | eng |
dc.subject.keyword | Male | spa |
dc.subject.keyword | Middle Aged | spa |
dc.subject.keyword | Protein-Serine-Threonine Kinases | spa |
dc.subject.keyword | Protozoan Proteins | spa |
dc.subject.keyword | T-Lymphocyte Subsets | spa |
dc.subject.keyword | Th1 Cells | spa |
dc.subject.keyword | Th2 Cells | spa |
dc.subject.keyword | Toxoplasmosis | spa |
dc.subject.keyword | Young Adult | spa |
dc.subject.keyword | IL10 | spa |
dc.subject.keyword | Interferon gamma | spa |
dc.subject.keyword | P30 protein | spa |
dc.subject.keyword | Peptides | spa |
dc.subject.keyword | ROP18 | spa |
dc.subject.keyword | Th1 | spa |
dc.subject.keyword | Th2 | spa |
dc.subject.keyword | Toxoplasma | spa |
dc.subject.keyword | Vaccine | spa |
dc.title | Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Torres-Morales2014_Article_Th1AndTh2ImmuneResponseToP30An.pdf
- Tamaño:
- 676.61 KB
- Formato:
- Adobe Portable Document Format
- Descripción: